Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Goodrx Holdings Inc Cl A (NQ: GDRX ) 4.890 -0.150 (-2.98%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Goodrx Holdings Inc Cl A < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Why GoodRx Holdings Stock Was Sinking This Week November 08, 2024 The company is growing key fundamentals. However, the improvements weren't enough to impress the market. Via The Motley Fool GoodRx (GDRX) Q3 2024 Earnings Call Transcript November 07, 2024 GDRX earnings call for the period ending September 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial GoodRx Reports Third Quarter 2024 Results November 07, 2024 From GoodRx Holdings, Inc. Via Business Wire GoodRx to Participate in Upcoming Investor Conferences November 04, 2024 From GoodRx Holdings, Inc. Via Business Wire GoodRx Unveils New E-commerce Platform, Launches with Opill® October 31, 2024 From GoodRx Via Business Wire GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults October 29, 2024 From GoodRx Via Business Wire Ronald E. Bruehlman Joins GoodRx Board of Directors October 28, 2024 From GoodRx Via Business Wire GoodRx Announces New Affordability Programs for Menopause Hormone Therapies October 23, 2024 From GoodRx Via Business Wire GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) August 16, 2024 Via Benzinga GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers October 16, 2024 From GoodRx Via Business Wire GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call October 10, 2024 From GoodRx Holdings, Inc. Via Business Wire GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray) September 26, 2024 From GoodRx Via Business Wire GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm September 25, 2024 From Bragar Eagel & Squire Via GlobeNewswire GoodRx to Participate in Upcoming Investor Conferences August 21, 2024 From GoodRx Holdings, Inc. Via Business Wire GoodRx (GDRX) Q2 2024 Earnings Call Transcript August 08, 2024 GDRX earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges August 08, 2024 GoodRx reported Q2 revenue of $200.61M, a 6% YoY increase. Prescription transactions revenue rose 7%, driven by 8% growth in Monthly Active Consumers. The company expects FY 2024 revenue at the lower... Via Benzinga GoodRx Reports Second Quarter 2024 Results August 08, 2024 From GoodRx Holdings, Inc. Via Business Wire MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday July 15, 2024 Via Benzinga GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call July 11, 2024 From GoodRx Holdings, Inc. Via Business Wire Ian T. Clark Joins GoodRx Board of Directors July 10, 2024 From GoodRx Holdings, Inc. Via Business Wire 3 Lawsuit-Laden Stocks to Dump Before Problems Multiply July 10, 2024 These stocks to sell face ongoing and past litigation, but that isn't the only sticking point in their long-term prospects. Via InvestorPlace Market Correction Alert: Sell These 3 Tech Stocks While You Can June 28, 2024 These tech stocks to sell combine shaky operational outlooks with underlying fundamental shakiness that don't bode well for the long-term. Via InvestorPlace GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S. June 26, 2024 From GoodRx Via Business Wire INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx June 21, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm June 21, 2024 From The Schall Law Firm Via Business Wire GoodRx Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GDRX June 21, 2024 From DJS Law Group Via Business Wire The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX) June 20, 2024 From The Law Offices of Frank R. Cruz Via Business Wire GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm June 20, 2024 From The Schall Law Firm Via Business Wire GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm June 18, 2024 From Schall Law Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Equinix and Encourages Investors to Contact the Firm June 17, 2024 From Bragar Eagel & Squire Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
